查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1990212

一般外科医疗设备市场：2026-2032年全球市场预测（依产品类型、技术、产品特性、最终用户和应用划分）

General Surgery Devices Market by Product Type, Technology, Product Nature, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年，一般外科医疗设备市场价值为202.7亿美元，预计到2026年将成长至215.1亿美元，复合年增长率为6.93%，到2032年将达到324.1亿美元。

主要市场统计数据
基准年 2025 202.7亿美元
预计年份：2026年 215.1亿美元
预测年份：2032年 324.1亿美元
复合年增长率 (%) 6.93%

简要概述技术整合、医疗领域的变化以及采购要求如何改变一般外科医疗设备的决策。

目前一般外科医疗设备的发展趋势是：技术融合加速、医疗环境不断变化，以及监管和经济监控力度加大。外科团队和采购经理正在适应不断变化的环境，例如，能量平台和微创手术器械等精准技术正被整合到标准诊疗流程中，同时医疗服务模式也在逐步将手术从住院病房转移到门诊和诊所。这种转变是由缩短住院时间、降低围手术全期风险和改善患者体验等临床需求所驱动的，从而导致医疗设备的选择、库存策略和培训计划的重组。

能源平台的发展、医疗保健的去中心化以及监管的加强，是如何从根本上改变竞争动态和临床工作流程的？

近年来，一般外科医疗设备领域经历了变革性的变化，这些变化正在改变竞争优势和临床管道。能量技术和混合器械的进步使外科医生能够更精准地进行止血和组织分离，并减少器械更换的频率。因此，手术时间得以缩短，手术室物流的复杂性也得以降低。同时，影像引导系统和平台化系统的扩展正在建立一个生态系统，在这个生态系统中，单一供应商的解决方案和可互通的配件正在影响采购行为和资本投资规划。

评估 2025 年美国关税调整将如何重塑整个生态系统的供应链策略、采购决策和采购风险管理。

美国关税将于2025年生效并逐步收紧，这为整个普通外科医疗设备生态系统带来了多层次的复杂性，影响着筹资策略、供应商关係和营运规划。由于关税变化会影响进口零件和成品的到货成本，医疗设备製造商被迫重新审视其供应链布局和与供应商的合约条款。为此，製造商正在进行供应商细分，识别单一采购模式带来的重大风险，并优先考虑对高风险零件采用双重采购和本土化生产方案。

一项全面的細項分析，揭示了整个普通外科医疗设备类别中临床需求、采购偏好和创新投资的交集。

详细的細項分析阐明了临床需求、采购偏好和创新投资如何在整个普通外科医疗设备领域相互交织。基于产品特性，市场分析分为电外科器械、腹腔镜器械、手术缝合器、超音波外科器械及血管封闭器械。在手术缝合器方面，手动缝合器和电动缝合器之间存在显着差异，分别适用于不同的手术流程和使用者人体工学需求。基于终端使用者需求模式，市场细分为门诊手术中心、诊所和医院，每种机构对器械尺寸、消毒流程和服务期望的要求各不相同。依适应症划分，临床重点领域包括盲肠切除手术、减重手术、结直肠手术、胆囊切除术和疝气修补术。在减重手术中，每种手术亚型，例如可调式胃束带术、胃绕道手术和袖状切除术，都有其独特的器械和缝合线的考量，这些考量会影响产品开发和培训需求。

针对特定区域的洞察揭示了监管差异、医疗保健服务模式和采购重点如何影响市场策略和产品策略。

区域趋势持续影响产品策略和市场进入方式，反映出全球市场在管理体制、医疗服务模式和资本基础设施方面的差异。在美洲，成本控制和可验证的临床疗效是医疗体系的重中之重，推动了对能够提高效率和提供可预测服务经济性的医疗设备的需求。此外，该地区某些手术的门诊模式应用广泛，这也影响了包装、便携性和灭菌设计的考量。

产品平台、证据产生和服务可靠性如何推动领先的医疗设备製造商之间的竞争差异化和伙伴关係策略？

一般外科医疗设备领域的竞争趋势呈现出多方面的差异化，涵盖创新、临床证据和服务交付。主要企业正投资于平台策略，将手术器械与专有耗材和数位化工具相结合，以提升外科医生的手术体验并创造可持续的收入来源。同时，专业製造商正利用特定解剖结构和手术流程的需求，提供针对特定应用和外科医生偏好的高性能手术器械。策略联盟和有针对性的收购在填补产品系列空白、加速获取互补技术以及优化全球分销网络方面继续发挥着至关重要的作用。

为製造商提供可操作的策略步骤，以调整模组化产品开发、证据计划和弹性供应链，从而与不断变化的临床和采购重点相符。

产业领导企业应优先考虑一系列切实可行的倡议，旨在使产品开发、商业策略和供应链韧性与不断变化的临床和经济现实相适应。首先，投资于模组化产品架构和可互通的配件，以降低单次手术成本并简化培训。这种方法支援在医院、门诊中心和诊所的部署，从而避免需要多种设备系列的情况。其次，制定全面的循证研究计划，将随机数据与可操作的真实世界结果相结合，以证明其临床价值，并为与大规模医疗系统和综合医疗网络进行合约谈判奠定坚实的基础。

我们采用严谨的混合方法研究，结合相关人员访谈、临床文献回顾和供应链情境分析，确保获得可操作且令人信服的见解。

支持这些发现的研究整合了定性专家访谈、与关键相关人员的咨询以及对临床文献、监管指令和供应链资讯披露的严格审查。主要研究包括与医院、门诊部和私人诊所的外科医生、采购经理、临床工程师和销售经理进行结构化讨论，以检验技术应用驱动因素、流程和预期服务。次要研究整合了同行评审的临床研究、监管指南和製造商技术文檔，以揭示技术能力和安全性概况。

综合结论强调，创新、证据和供应链韧性的协调一致决定了谁能获得临床信任和市场支持。

总而言之，技术进步、医疗保健分散化以及影响采购和临床应用的经济压力正在重塑普通外科医疗设备的市场格局。基于能源的平台、微创手术器械和模组化器械架构的融合正在提高手术效率和病患疗效，而关税和供应链趋势则促使人们重新评估采购和製造策略。需要针对特定市场采取相应的策略，以应对监管的严格性和医疗服务模式的区域差异。从产品特性、最终用户、应用、技术、分销管道和产品性质等方面进行细分，可以明确投资和商业化工作的重点领域，从而最大限度地发挥影响力。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：通用外科医疗设备市场：依产品特性划分

  • 电外科设备
  • 腹腔镜器械
  • 手术缝合器
    • 手动订书机
    • 电动订书机
  • 超音波手术设备
  • 血管密封装置

第九章：通用外科医疗设备市场：依技术划分

  • 雷射
  • 机械的
  • 高频
  • 超音波

第十章 普通外科医疗设备市场：依产品特性划分

  • 一次性的
  • 可重复使用的

第十一章 普通外科医疗设备市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院

第十二章 普通外科医疗设备市场：依应用领域划分

  • 盲肠切除手术
  • 减重手术
    • 可调式胃束带手术
    • 胃绕道手术
    • 袖状切除术
  • 大肠直肠/直肠手术
  • 胆囊切除术
  • 疝气修补术

第十三章：普通外科医疗设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 普通外科医疗设备市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 普通外科医疗设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国一般外科医疗设备市场

第十七章：中国普通外科医疗设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson, and Company
  • Cardinal Health, Inc.
  • Carl Zeiss Meditec AG
  • CooperSurgical, Inc.
  • Delta Med SpA
  • Ecolab Inc.
  • Globus Medical, Inc.
  • Henry Schein, Inc.
  • Innomed, Inc.
  • Johnson & Johnson Services Inc
  • Koninklijke Philips NV
  • Medica Europe BV
  • Medtronic PLC
  • Olympus Corporation
  • Schott AG
  • Siemens Healthcare GmbH
  • Smith & Nephew PLC
  • Stryker Corporation
  • Teleflex Incorporated
  • Thermo Fisher Scientific Inc.
Product Code: MRR-99555D55052D

The General Surgery Devices Market was valued at USD 20.27 billion in 2025 and is projected to grow to USD 21.51 billion in 2026, with a CAGR of 6.93%, reaching USD 32.41 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 20.27 billion
Estimated Year [2026] USD 21.51 billion
Forecast Year [2032] USD 32.41 billion
CAGR (%) 6.93%

A concise overview of how technological convergence, shifting care settings, and procurement imperatives are reshaping decision-making across general surgery devices

The contemporary landscape for general surgery devices is defined by accelerating technological convergence, shifting care settings, and heightened regulatory and economic scrutiny. Surgical teams and procurement leaders are navigating an environment where precision technologies such as energy-based platforms and minimally invasive instrumentation are being integrated into standard practice, while healthcare delivery models progressively migrate procedures away from inpatient wards toward ambulatory and clinic environments. This transition is driven by clinical priorities to reduce length of stay, mitigate perioperative risk, and improve patient experience, and it is reshaping device selection, inventory strategies, and training programs.

Importantly, providers are balancing clinical performance with total cost of ownership, creating stronger demand signals for device modularity, interoperability, and consumable efficiency. At the same time, device manufacturers are responding by prioritizing user-centered design, evidence generation, and lifecycle support to differentiate within competitive tenders. As stakeholders adapt to these dynamics, strategic decision-making requires a nuanced appreciation of technology adoption patterns, end-user preferences, and the regulatory and reimbursement ecosystems that collectively determine product trajectory and clinical uptake.

How advances in energy-based platforms, care decentralization, and regulatory scrutiny are fundamentally transforming competitive dynamics and clinical workflows

Over recent years the landscape of general surgery devices has experienced transformative shifts that are altering competitive advantage and clinical pathways. Advances in energy-based technologies and hybrid instrumentation are enabling surgeons to achieve hemostasis and tissue division with greater precision and fewer instrument exchanges, which in turn reduces operative time and the complexity of OR logistics. Concurrently, the expansion of image-guided and platform-based systems has fostered an ecosystem where single-vendor solutions and cross-compatible accessories influence purchasing behavior and capital planning.

Moreover, organizational strategy is being influenced by decentralization of care: ambulatory surgical centers and outpatient clinics are increasing procedural volume for select general surgery indications, prompting suppliers to introduce compact, cost-effective devices optimized for smaller footprints. Regulatory updates and heightened post-market surveillance have elevated the need for robust safety data and traceability, prompting manufacturers to invest in clinical studies and digital post-market monitoring. Collectively, these shifts favor manufacturers that can demonstrate clinical differentiation, supply reliability, and responsive service models, while health systems are increasingly prioritizing partners who support value-based care initiatives and operational resilience.

Assessment of how 2025 United States tariff adjustments are reshaping supply chain strategies, sourcing decisions, and procurement risk management across the ecosystem

The introduction and escalation of United States tariff measures in 2025 have introduced a layered complexity that affects sourcing strategies, supplier relationships, and operational planning across the general surgery devices ecosystem. Tariff changes influence landed costs for imported components and finished devices, which has prompted device companies to reassess their supply chain footprints and contractual terms with suppliers. In response, manufacturers are conducting supplier segmentation exercises to identify critical single-source exposures and to prioritize dual-sourcing or onshoring options for high-risk components.

Consequently, procurement teams and commercial leaders are revisiting pricing strategies and negotiating longer-term agreements that include price adjustment mechanisms and shared risk provisions. Importantly, the tariffs have accelerated conversations about vertical integration for certain consumables and subassemblies, while simultaneously incentivizing investment in regional manufacturing capabilities to reduce exposure to cross-border tariff volatility. From the provider perspective, hospitals and ambulatory centers are increasingly scrutinizing total procurement costs and supplier service levels, favoring manufacturers that can demonstrate nimble supply continuity plans and transparent cost structures. Moving forward, stakeholders must factor in tariff-related operational contingencies when modeling procurement cycles and capital acquisitions to preserve margin and patient access.

Comprehensive segmentation analysis revealing where clinical demand, procurement preferences, and innovation investments intersect across the general surgery devices category

A granular view of segmentation provides clarity on where clinical demand, procurement preferences, and innovation investments converge across the general surgery devices category. Based on product type the market is examined through electrosurgical devices, laparoscopic instruments, surgical staplers, ultrasonic surgical devices, and vessel sealing devices; within surgical staplers an important distinction exists between manual staplers and powered staplers, each addressing different procedural workflows and user ergonomics. Based on end user demand patterns are differentiated across ambulatory surgical centers, clinics, and hospitals, with each setting generating distinct requirements for device size, sterilization workflows, and service expectations. Based on application clinical focus areas include appendectomy, bariatric surgery, colorectal surgery, gallbladder removal, and hernia repair; within bariatric surgery, procedural subtypes such as adjustable gastric banding, gastric bypass, and sleeve gastrectomy present unique instrumentation and staple-line considerations that influence product development and training needs.

Based on technology the landscape is segmented across laser, mechanical, radiofrequency, and ultrasonic modalities, each offering particular advantages in tissue effect, thermal spread, and user adoption curves. Based on distribution channel commercial pathways vary across direct sales models, distributor sales, and online platforms, affecting margin structures, market reach, and post-sale support. Lastly, based on product nature devices are categorized as disposable or reusable, which has implications for procurement cycles, environmental considerations, and clinical preference. Synthesizing these segmentation lenses highlights where innovation investment, commercialization strategy, and clinical evidence generation should be concentrated to capture distinct use-case value and to align product roadmaps with end-user workflows.

Region-specific insights that clarify how regulatory variation, care delivery models, and procurement priorities influence market approach and product strategy

Regional dynamics continue to shape product strategy and go-to-market approaches, reflecting divergent regulatory regimes, care delivery models, and capital infrastructure across global markets. In the Americas, healthcare systems place a premium on cost containment and demonstrable clinical outcomes, driving demand for devices that deliver efficiency gains and predictable service economics. This region also demonstrates strong adoption of ambulatory care models for select procedures, which informs packaging, portability, and sterilization design considerations.

In Europe, Middle East & Africa the regulatory landscape is heterogeneous, with varying approval timelines and reimbursement pathways that necessitate tailored market entry and evidence strategies; providers in this region frequently emphasize clinical safety and long-term durability when selecting devices. Meanwhile, the Asia-Pacific region exhibits pronounced heterogeneity in hospital capacity, procedure volumes, and investment in surgical infrastructure, creating opportunities for scalable, cost-effective technologies as well as the need for localized training and service networks. Across all regions, stakeholders are increasingly evaluating environmental policies and lifecycle impacts of disposable versus reusable devices, which in turn influences procurement frameworks and supplier selection. Taken together, these regional insights should guide manufacturers in prioritizing regulatory investments, distribution partnerships, and customer support models that reflect local practice patterns and institutional priorities.

How product platforms, evidence generation, and service reliability are driving competitive differentiation and partnership strategies among leading device manufacturers

Competitive dynamics within the general surgery devices sector are characterized by multi-dimensional differentiation across innovation, clinical evidence, and service delivery. Leading firms are investing in platform strategies that bundle instruments with proprietary consumables and digital tools to enhance surgeon experience and to create recurring revenue streams. At the same time, specialized manufacturers are capitalizing on niche anatomical and procedural requirements, delivering high-performance instruments tailored to specific applications and surgeon preferences. Strategic partnerships and targeted acquisitions continue to play a role in filling portfolio gaps, accelerating access to complementary technologies, and optimizing global distribution networks.

Service excellence and supply reliability are emerging as significant differentiators, particularly for customers operating across ambulatory centers and decentralized care settings where inventory and sterilization capacity may be constrained. Additionally, firms that proactively engage in real-world evidence generation and post-market surveillance secure stronger clinical adoption and payer acceptance. For market entrants, success depends on clear value propositions, nimble commercialization models, and credible clinical champions to support adoption. Established players must focus on sustaining innovation pipelines while streamlining operations to defend against margin pressure and evolving procurement modalities.

Actionable strategic moves for manufacturers to align modular product development, evidence programs, and resilient supply chains with shifting clinical and procurement priorities

Industry leaders should prioritize a set of actionable initiatives designed to align product development, commercial strategy, and supply chain resilience with evolving clinical and economic realities. First, invest in modular product architectures and interoperable accessories that reduce per-procedure costs and simplify training; this approach supports adoption across hospitals, ambulatory centers, and clinics and mitigates the need for multiple device families. Next, develop comprehensive evidence-generation programs that combine randomized data with pragmatic real-world outcomes to demonstrate clinical value and support favorable contracting conversations with large health systems and integrated delivery networks.

Simultaneously, strengthen supply chain resilience by diversifying suppliers, negotiating flexible long-term agreements, and exploring regional manufacturing options to reduce exposure to tariff and logistics volatility. Enhance post-sale value by offering bundled service packages, remote training, and data-driven maintenance programs that reduce downtime and improve customer satisfaction. Finally, align commercialization channels by balancing direct sales capabilities with distributor partnerships and digital platforms to maximize reach while preserving margin. Implementing these recommendations will enable companies to accelerate adoption, protect margin, and adapt to shifting care models and regulatory expectations.

A rigorous mixed-methods research approach combining stakeholder interviews, clinical literature review, and supply chain scenario analysis to ensure actionable and defensible insights

The research underpinning these insights integrates qualitative expert interviews, primary stakeholder consultations, and a rigorous review of clinical literature, regulatory communications, and supply chain disclosures. Primary research included structured discussions with surgeons, procurement directors, clinical engineers, and commercial leaders across hospital, ambulatory, and clinic settings to validate adoption drivers, procedural workflows, and service expectations. Secondary analysis synthesized peer-reviewed clinical studies, regulatory guidance, and manufacturer technical documentation to map technology capabilities and safety profiles.

Analytical frameworks employed scenario analysis, supplier risk mapping, and segmentation overlays to interpret how tariffs, regional regulatory differences, and distribution channels interact with product adoption. Triangulation methods were used to reconcile qualitative insights with documented evidence, ensuring that conclusions reflect both lived clinical experience and published data. Throughout the process, attention was paid to data provenance, potential bias in self-reported supplier performance, and the need for transparent assumptions when interpreting supply chain impacts. This methodology supports robust, actionable findings while maintaining clarity on evidence sources and analytical limitations.

A synthesized conclusion emphasizing how alignment of innovation, evidence, and supply chain resilience will determine who captures clinical trust and market preference

In summary, the general surgery devices landscape is being reshaped by technological evolution, decentralization of care, and economic pressures that together influence procurement and clinical adoption. Energy-based platforms, minimally invasive instrumentation, and modular device architectures are converging to deliver improved operative efficiency and patient outcomes, while tariffs and supply chain dynamics are prompting reassessments of sourcing and manufacturing strategies. Regional variations in regulatory rigor and care delivery models require tailored market approaches, and segmentation across product type, end user, application, technology, distribution channel, and product nature highlights where targeted investment and commercialization focus will yield the greatest impact.

Going forward, manufacturers and healthcare providers that prioritize interoperability, evidence generation, and supply chain resilience will be best positioned to capture clinical trust and operational preference. By aligning product roadmaps with institutional needs and by investing in service models that reduce adoption friction, stakeholders can translate innovation into measurable clinical and economic value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. General Surgery Devices Market, by Product Type

  • 8.1. Electrosurgical Devices
  • 8.2. Laparoscopic Instruments
  • 8.3. Surgical Staplers
    • 8.3.1. Manual Staplers
    • 8.3.2. Powered Staplers
  • 8.4. Ultrasonic Surgical Devices
  • 8.5. Vessel Sealing Devices

9. General Surgery Devices Market, by Technology

  • 9.1. Laser
  • 9.2. Mechanical
  • 9.3. Radiofrequency
  • 9.4. Ultrasonic

10. General Surgery Devices Market, by Product Nature

  • 10.1. Disposable
  • 10.2. Reusable

11. General Surgery Devices Market, by End User

  • 11.1. Ambulatory Surgical Center
  • 11.2. Clinic
  • 11.3. Hospital

12. General Surgery Devices Market, by Application

  • 12.1. Appendectomy
  • 12.2. Bariatric Surgery
    • 12.2.1. Adjustable Gastric Banding
    • 12.2.2. Gastric Bypass
    • 12.2.3. Sleeve Gastrectomy
  • 12.3. Colorectal Surgery
  • 12.4. Gallbladder Removal
  • 12.5. Hernia Repair

13. General Surgery Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. General Surgery Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. General Surgery Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States General Surgery Devices Market

17. China General Surgery Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3M Company
  • 18.6. Abbott Laboratories
  • 18.7. B. Braun Melsungen AG
  • 18.8. Becton, Dickinson, and Company
  • 18.9. Cardinal Health, Inc.
  • 18.10. Carl Zeiss Meditec AG
  • 18.11. CooperSurgical, Inc.
  • 18.12. Delta Med S.p.A.
  • 18.13. Ecolab Inc.
  • 18.14. Globus Medical, Inc.
  • 18.15. Henry Schein, Inc.
  • 18.16. Innomed, Inc.
  • 18.17. Johnson & Johnson Services Inc
  • 18.18. Koninklijke Philips N.V.
  • 18.19. Medica Europe B.V.
  • 18.20. Medtronic PLC
  • 18.21. Olympus Corporation
  • 18.22. Schott AG
  • 18.23. Siemens Healthcare GmbH
  • 18.24. Smith & Nephew PLC
  • 18.25. Stryker Corporation
  • 18.26. Teleflex Incorporated
  • 18.27. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GENERAL SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GENERAL SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA GENERAL SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY MANUAL STAPLERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY MANUAL STAPLERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY MANUAL STAPLERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY POWERED STAPLERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY POWERED STAPLERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY POWERED STAPLERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC SURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC SURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC SURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY VESSEL SEALING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY VESSEL SEALING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY VESSEL SEALING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY RADIOFREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY RADIOFREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ULTRASONIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY APPENDECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY APPENDECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY APPENDECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY COLORECTAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY COLORECTAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY COLORECTAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GALLBLADDER REMOVAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GALLBLADDER REMOVAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GALLBLADDER REMOVAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY HERNIA REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY HERNIA REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY HERNIA REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 155. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 158. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 160. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. GCC GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 179. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 182. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 184. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. G7 GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 187. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 190. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 192. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. NATO GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL GENERAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA GENERAL SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA GENERAL SURGERY DEVICES MARKET SIZE, BY SURGICAL STAPLERS, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA GENERAL SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA GENERAL SURGERY DEVICES MARKET SIZE, BY PRODUCT NATURE, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA GENERAL SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA GENERAL SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA GENERAL SURGERY DEVICES MARKET SIZE, BY BARIATRIC SURGERY, 2018-2032 (USD MILLION)